All In Biotech

Free tool

FAERS Monitor: Lupkynis

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 213716 or its brand name (Lupkynis, Voclosporin). Reports on generic versions are filed under their own applications.

Reports

9,788

Serious

1,987

20% of reports

Hospitalization

849

Death reported

61

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • therapy interrupted991
  • product dose omission issue870
  • hypertension807
  • headache764
  • nausea715
  • fatigue625
  • diarrhoea605
  • proteinuria557
  • blood pressure increased440
  • product use issue427
  • glomerular filtration rate decreased380
  • vomiting369
  • abdominal discomfort356
  • arthralgia337
  • dizziness311

Reports by year received

View as table
YearReports
20191
2021431
20221,006
20231,506
20242,002
20252,316
20262,526

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,371 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
glomerular filtration rate decreasedSignal38068.562.024,461
proteinuriaSignal55764.859.733,939
therapy interruptedSignal99130.228.527,659
hypertensionSignal8078.27.75,139
product dose omission issueSignal8706.46.03,980
blood pressure increasedSignal4406.25.71,922
product use issueSignal4274.94.51,327
abdominal discomfortSignal3564.64.1994
headacheSignal7642.62.4787
diarrhoeaSignal6052.01.9318
nausea7151.91.8338
arthralgia3371.71.6108
fatigue6251.71.6197
vomiting3691.71.5105
dizziness3111.31.227

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.